Go Pro

Assembly Biosciences (ASMB) Earnings Date, Estimates & Call Transcripts

Assembly Biosciences logo
$32.16 +2.15 (+7.16%)
As of 12:40 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Assembly Biosciences Earnings Summary

Assembly Biosciences issued Q2 2026 earnings on August 13, 2026, reporting an EPS of -$0.20, which topped the consensus estimate of -$0.72 by $0.52. Quarterly revenue was reported to be $13.37 million, above analysts' expectations of $8.60 million. With a trailing EPS of $1.02 and a P/E Ratio of 30.64, Assembly Biosciences' earnings are expected to decrease next year, from $1.90 to ($0.77) per share.

Latest Q2
Earnings Date
Aug. 13Estimated
Consensus EPS
(Aug. 13)
-$0.72
Actual EPS
(Aug. 13)
-$0.20 Beat By $0.52
Actual Revenue
(Aug. 13)
$13.37M

Q2 2026 Earnings Resources

Get Assembly Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Assembly Biosciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ASMB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ASMB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Assembly Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.73-$0.73-$0.73
Q2 20261-$0.70-$0.70-$0.70
Q3 20261-$0.69-$0.69-$0.69
Q4 20261$3.69$3.69$3.69
FY 2026 4 $1.57 $1.57 $1.57
Q1 20271-$0.16-$0.16-$0.16
Q2 20271-$1.18-$1.18-$1.18
Q3 20271-$1.18-$1.18-$1.18
Q4 20271$1.66$1.66$1.66

Assembly Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026-$0.7242-$0.20+$0.5242-$0.20$8.60M$13.37M
5/7/2026Q1 2026-$0.65-$0.54+$0.11-$0.54$9.27M$8.21M
3/19/2026Q4 2025-$0.51$2.48+$2.99$2.48$7.42M$42.47M
11/10/2025Q3 2025-$0.50-$0.72 -$0.22-$0.72$7.46M$10.79M
8/6/2025Q2 2025-$1.73-$1.33+$0.40-$1.33$5.30M$9.63M
5/8/2025Q1 2025-$2.01-$1.17+$0.84-$1.17$7.41M$9.42M
3/20/2025Q4 2024-$1.75-$1.57+$0.18-$1.57$7.05M$7.36M

Assembly Biosciences Earnings - Frequently Asked Questions

Assembly Biosciences (NASDAQ:ASMB) last announced its quarterly earning data on Thursday, August 13, 2026. Learn more on ASMB's earnings history.

In the previous quarter, Assembly Biosciences (NASDAQ:ASMB) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.72) by $0.52. Learn more on analysts' earnings estimate vs. ASMB's actual earnings.

Assembly Biosciences (NASDAQ:ASMB) has a recorded annual revenue of $72.30 million.

Assembly Biosciences (NASDAQ:ASMB) has a recorded net income of -$6.12 million. ASMB has generated $1.02 earnings per share over the last four quarters.

Assembly Biosciences (NASDAQ:ASMB) has a trailing price-to-earnings ratio of 30.41 and a forward price-to-earnings ratio of 16.44.

Assembly Biosciences' earnings are expected to decrease from $1.90 per share to ($0.77) per share in the next year.


Earnings data for NASDAQ:ASMB is sourced from Fiscal.ai, with the most recent quarter reported on 8/13/2026. New results are added as companies report their earnings.
From Our Partners